Role of tyrosine-kinase inhibitors in myeloproliferative neoplasms: comparative lessons learned

Role of tyrosine-kinase inhibitors in myeloproliferative neoplasms: comparative lessons learned

Javier Pinilla-Ibarz, Kendra L Sweet, Gabriela M Corrales-Yepez, Rami S Komrokji Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA Abstract: An important pathogenetic distinction in the classification of myeloproliferative neoplasms (MPNs) is th...

Full description

Bibliographic Details
Main Authors: Pinilla-Ibarz J, Sweet KL, Corrales-Yepez GM, Komrokji RS
Format: Article
Language:English
Published: Dove Medical Press 2016-08-01
Series:OncoTargets and Therapy
Subjects:
chronic myeloid leukemia
myelofibrosis
tyrosine kinase inhibitors
ruxolitinib
JAK inhibitor
Online Access:https://www.dovepress.com/role-of-tyrosine-kinase-inhibitors-in-myeloproliferative-neoplasms-com-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/role-of-tyrosine-kinase-inhibitors-in-myeloproliferative-neoplasms-com-peer-reviewed-article-OTT

Similar Items